Send us Feedback

Solvay S.A. (SVYSY)
Analysis
SUMMARY
BULLS
BEARS
Data
STOCK CHART
QUOTE AND NEWS
New Published Data Demonstrate Long-Term Safety, Efficacy and Tolerability of Watson's RAPAFLO(R) (silodosin) for Benign Prostatic Hyperplasia (BPH) Symptom Relief
PR Newswire  Dec 9  Comment 
CORONA, Calif., Dec. 9 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that the results of an open-label extension of two Phase 3 studies, published in the December issue of the peer-reviewed journal Urology,
Ruling could prevent whistleblower suits
FiercePharma  Dec 7  Comment 
Things may have just gotten tougher for potential pharma whistleblowers. Last Friday, the U.S. Court of Appeals for the Eleventh Circuit in Atlanta upheld a lower court's dismissal of a whistleblower case filed against Solvay Pharmaceuticals in...
Solvay Group Selects Reflex Systems to Manage, Secure Virtual Environment
Cloud Computing  Dec 1  Comment 
Reflex Systems, the pioneer in virtualization management, security and compliance, today announced that The Solvay Group has implemented Reflex VMC (Virtualization Management Center) to manage more than 50 servers with 500 VMware-based virtual...
SOLVAY : Operating result in the third quarter (EUR 285 million) in line with last year's (-2%) and improved compared to the two preceding quarters
Marketwire  Oct 29  Comment 
BRUSSELS, BELGIUM -- (Marketwire) -- 10/29/09 -- REGULATED INFORMATION Operating result in the third quarter (EUR 285 million) in line with last year's (-2%) and improved compared to the two preceding quarters - Sales (EUR 6,286 million) down by 13%
Sinclair finds new CEO to lead hunt for acquisitions
FierceBiotech  Oct 12  Comment 
Hot on the trail of new acquisitions, the UK's Sinclair Pharma says it struck a deal to buy two burn creams from Solvay and has found a new CEO to replace Michael Flynn, who is retiring. Christopher Spooner, who founded HealthCor Management UK,...
Consolidation, layoffs hit Atlanta drugmakers
FiercePharma  Oct 9  Comment 
As Big Pharma consolidates and restructures, sympathy has gone out to New Jersey, where many drugmakers make their U.S. home. Layoffs are expected to hurt local economies, not only because of lost jobs and personal income, but real estate...
Clariant seen as possible Solvay target
Reuters  Sep 30  Comment 
(Corrects to change "named" to "seen" in headline; also raises share price paragraphs)
Investors lap up Dishman shares as Solvay-Abbott strike deal
The Economic Times  Sep 30  Comment 
Dishman Pharmaceuticals is likely to be in the pink of health after its Belgian client Solvay Group has been taken over by US drug-maker Abbott.



Thank you for your suggestion
more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


You may also be interested in articles related to Solvay S.A. (SVYSY):
 
TOP CONTRIBUTORS
Sr. Director
Peter Maa

Solvay SA is a chemicals and pharmaceuticals company. The Company operates in three sectors: pharmaceuticals, chemicals and plastics. The pharmaceuticals sector is engaged in the therapeutic fields of cardiometabolic, neuroscience, flu vaccines, pancreatic enzymes and gastroenterology. The chemicals sector specializes in soda ash, advanced functional minerals, electrochemistry, fluorinated products, hydrogen peroxide and persalts. Plastics sector specializes in specialty and vinyls. In October 2008, the Company acquired Alexandria Sodium Carbonate Company (ASCC) in Egypt from Holding Company for Chemical Industries (HCCI). In February 2008, it announced that it has completed the sale of its caprolactones business to Perstorp. In March 2008, the Company announced that it has finalized the sale of its subsidiary, Solvay Engineered Polymers (SEP), which is a supplier of polypropylene compounds, to LyondellBasell Industries. [1]

Retrieved from "http://www.wikinvest.com/stock/Solvay_S.A._(SVYSY)"
Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki